革新技术

认识早期鼻咽癌筛查了解NGS技术相关研究报告

clinical papers banner

clinical papers banner

相关研究报告

Take2 Prophecy™ 早期鼻咽癌筛查所使用的技术是由屡获殊荣的香港中文大学顶尖研究团队发明。团队曾以该技术为2万名人士进行鼻咽癌筛查，其临床研究结果分别于《新英格兰医学杂志》以及《美国国家科学院院刊》刊登，有关详情请浏览以下刊物：

Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma

Contributed by Y. M. Dennis Lo, April 26, 2018 (sent for review March 13, 2018; reviewed by Luis Diaz and Klaus Pantel)

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for nasopharyngeal carcinoma. We conducted a prospective study to investigate whether EBV DNA in plasma samples would be useful to screen for early nasopharyngeal carcinoma in asymptomatic persons.

网上预约
优惠码 NEW330